gender differences in felines, with the rate of CYP2D6 metabolism greater in females than in males, and an inverse relationship reported in CYP3A (Shah, Sanda, Regmi, Sasaki, & Shimoda, 2007) . A comparison between human, equine, canine, and feline CYP probe substrates found significantly higher activity of coumarin in humans compared to felines, higher tolbutamide activity in human and equine compared to cat, higher dextromethorphan O-demethylase and chlorzoxazone 6-hydroxylase activity in equine compared cat, and higher testosterone 6B-hydroxylase activity in humans compared to cat (Chauret, Gauthier, Martin, & Nicoll-Griffith, 1997 ).
Compared to the canine CYP repertoire and function, only a few individual feline CYP isoforms have been described. Reported differences between canine and feline include feline CYP2B6 expression in lung and duodenum but not in the liver (Okamatsu et al., 2017) and duplication of CYP2E (Tanaka et al., 2005) . Additional feline CYP previously described includes CYP2A13 (Okamatsu et al., 2015) , 3A131, 3A132 (Honda et al., 2011) , and 2D6 (Komatsu et al., 2010) . While probe substrates suggest differences between the various species, the limited information regarding CYP expression in the feline limits the ability to predict drug efficacy and safety.
Next-generation sequencing accurately sequences the entire genome or transcriptome of an organism. RNA sequencing (RNASeq) has proven to be a powerful tool for quantifying gene expression and transcripts, discovering alternative splicing sites, detecting gene fusions, mapping transcription pathways, and the detection of single-nucleotide variations (Chen, Wang, & Shi,2011; Marguerat & Bahler, 2010) . This technology has been used to map cell response to feline immunodeficiency virus (Ertl & Klein, 2014) , identify orthologs to genes in the published genome (Hong, Li, Schmidt-Kuntzel, Warren, & Barsh, 2011) , and determine a missense mutation in HES7 leading to short tails in Asian domestics cats Xu et al., 2016) . Currently, a large-scale, community research project entitled "99 Lives" is underway, which uses whole-genome and transcriptome sequencing to identify genetic variation between feline breeds, identify mutations of health concern, and provide individual feline sequences for clinical research (Aberdein et al., 2017; Leslie A Lyons, 2016; Mauler et al., 2017; Oh et al., 2017) .
The quantification of gene expression from short-read RNA-seq data depends on binning reads by their transcript of origin. This may be performed by aligning to a de novo transcript assembly or to a reference genome annotated with genes and transcripts. Annotated reference genomes allow annotated genes to be overlaid with other features including noncoding transcripts and variants (Wit et al., 2012) , as well as homologous regions to be compared across individuals and species. With the availability of publicly available reference genomes via NCBI and Ensembl, alignment or mapping to the reference genome is generally the method of choice, particularly when comparing gene expression between individuals. Each sample's sequenced reads are compared to the whole-genome assembly and aligned to the position of the greatest similarity. If a read matches to multiple places on the reference, it is discarded as one cannot identify which is the correct location. Once aligned, reads are binned by gene or transcript based on unique sequence (such as exon-exon junctions or exons unique to a single gene or transcript) or random assignment to one of the pool of genes or transcripts to which they match. The shorter the read, the higher the probability of a nonunique assignment, which is a source of error in RNA-seqbased gene expression measures.
Recently, RNA-seq was used to characterize the CYP transcriptome in canine liver, lung, duodenum, kidney, and whole blood (Visser et al., 2017) . The purpose of this study was to identify and quantify CYP expression in five tissues collected from the domestic feline and combine the sequenced transcriptomes with 99 Lives transcriptomes to characterize CYP isoform expression in multiple tissues.
| ME THODOLOGY
Subjects had served as a control group for a separate study. 
| Sample collection
Male (n = 2) and female (n = 2), healthy, adult domestic felines were euthanized via an intravenous injection of sodium pentobarbital; blood (n = 4) and sections of liver (n = 4), kidney (n = 4), lung (n = 4), and duodenum (n = 4) were collected. Blood (PAXgene Blood RNA Tube, PreAnalytiX, Hombrechtikon, Switzerland) and tissues (RNAlater ® , Qiagen, Valencia, CA, USA) were kept frozen at −80°C until processing. Liver and kidney's total RNA was isolated using the RNeasy Mini protocol (Qiagen ® ), lung and duodenum isolated using the Fibrous RNeasy protocol (Qiagen ® ), and blood using PAXgene Blood RNA Kit, PreAnalytiX (Qiagen ® ). RNA integrity number (RIN) (Bioanalyzer 2100, Agilent Technologies, Santa Clara, CA, USA) and cDNA quality (NanoDrop 8000, Thermo Scientific, Wilmington, DE, USA) were evaluated before cDNA library preparation (Schroeder et al., 2006 
| RNA-seq analysis and statistics
RNA-seq analysis was performed using CLC Genomics Workbench ensure that all known feline CYP were accounted. CYP2B6 was not present in the annotated feline genome, and the sequence information was found in GenBank (ncbi.gov, KU198409.1) and included in the genome (Okamatsu et al., 2017) . Each gene was checked in Ensembl and NCBI and described including the Ensembl and NCBI identification, whether the gene was modeled based on automated pipeline or provided by an outside source requiring additional curation and reported chromosomal location (Table 1) .
| RE SULTS

| Data from both healthy and diseased cats were analyzed
The number of paired reads/sample averaged 46.4 million (M) with liver having the lowest tissue total (144M) and kidney having the highest (248M). Greater than 90% of reads mapped to the feline reference genome or all tissues, with an average of 95.6% and 80% mapping uniquely. The genome annotations accounted for greater than 85% of mapped reads (i.e., less than 15% of reads mapping to intergenic regions) for most samples with an exception for kidney (17.5% mapped to intergenic regions) and neural tissue such as spinal cord (16.1%) and brain (up to 21%). A total of 42 CYP were identified across 20 tissues (Supporting Information Table S1 ). The numbers of biologic replicates varied between the samples, ranging from six for kidney, brain, and liver to only one for the spinal cord, testes, uterus, heart, muscle, pancreas, salivary gland, thymus, and bone marrow.
The highest CYP isoform transcript expression was liver (n = 5), with 29 individual CYP identified, and the lowest was pancreas (n = 1) with only three CYP isoform transcripts identified (Figure 1a) . Based on the CYP function (Table 1) 
| D ISCUSS I ON
This study is the first to characterize the global CYP expression in the domestic cat, providing insight into different tissue CYP transcript profiles at multiple sites in the body. Whole-transcriptome sequencing from multiple sources was combined to increase the number of reported feline CYP isoforms from seven to 42. A major CYP xenobiotic family, CYP2C, was also identified and described for the first time.
The nomenclature utilized in this report is based on the currently publically available nomenclature on Ensembl. This is based on completed referenced sequences and automated annotations. Complete sequencing and submission of the sequences to the CYP nomenclature committee are necessary to improve the naming and association of the CYPs presented in this article (Nelson, 2006 (Nelson, , 2009 ).
All of the recognized major drug-metabolizing CYP families (CYP1A, 2A, 2B, 2C, 2D, and 3A) were identified in at least one tissue. Previous reports on CYP2B6 expression found negligible transcript and protein expression in the liver, but transcript and protein expression were predominant in the lung and detectable in the small intestine (Okamatsu et al., 2017) . RNA-seq found negligible transcript expression in the TA B L E 1 Identified feline CYP including chromosome and location and reported function in humans based on the major substrate category. In addition to the chromosome location, the strand direction is noted if an ortholog was used. N/A indicates that the location could not be determined liver and blood, with the highest expression in the lung, followed by kidney and duodenum. Drugs requiring CYP2B6 for metabolism can be expected to have slower metabolism in the feline compared to the canine due to the lack of CYP2B6 in the liver. Reported CYP2B6 substrates include drugs such as methadone (Kharasch & Stubbert, 2013) , cyclophosphamide (Bachanova et al., 2015) , propofol, diazepam, midazolam, ketamine, S-medetomidine, R-medetomidine, warfarin, and phenytoin (Martinez et al., 2013 TA B L E 1 (Continued) The CYP3A family consists of CYP3A131 and 3A132, with previous reports of CYP3A131 mRNA transcript expression in small intestine and liver, and limited CYP3A132 expression only in liver (Honda et al., 2011) . RNA-seq results indicate that CYP3A131 expression was present in all five experimentally acquired tissues examined, with the majority of expression in liver and duodenum. In contrast to reported results, CYP3A132 expression was higher in the liver than CYP3A131 transcript expression and was present in the remaining four tissues, but to a lesser extent than CYP3A131 (Okamatsu et al., 2016) . The two isoform transcripts are reported to be 94. canines due to the described large enzyme pocket allowing a variety of substrates to be metabolized (Ekins, Stresser, & Williams, 2003) .
The impact of different isoforms on drug metabolism has not been established, but different human and canine isoforms have diverse drug metabolism for the CYP3A family (Court, 2013) , and whether this is also true in feline CYP3A needs to be explored further.
CYP2E has been reported to be duplicated in the literature (named CYP2E1 and CYP2E2), but annotation in Ensembl and NCBI does not consistently differentiate these isoforms. As each copy has been described to have different tissue distributions (liver, kidney, lung, stomach, gastric gland, pyloric gland, small intestine, and pancreas for CYP2E1, and liver and mononuclear cells for 2E2 (Tanaka et al., 2005) ), ambiguity between them could lead to misunderstanding of function. In Ensembl, the isoform is denoted as CYP2E1, but in NCBI, the same gene is denoted at CYP2E2. This lack of consistent and complete annotation prevents proper identification of two separate isoform mRNA transcripts if present.
CYP2C21 and CYP2C41 are reported for the first time in the feline. Detection of these two isoforms was based on the automated Ensembl annotation prediction algorithm using homology in genome sequence (Curwen et al., 2004) . Therefore, the individual transcripts have not been independently sequenced and protein content verified, key components necessary to determine the impact on drug metabolism. The two CYP2C isoforms were detected in moderate abundance across several animals, compared to the canine CYP2C family where only a small percentage of canines report to express both isoforms (Court, 2013; Martinez et al., 2013 (Kimble et al., 2014) . Compared to the canine genome annotations, the accuracy and depth of feline annotation are extremely limited, leading to discrepancies between the two databases and the need for manual curation of the genome. Additional research into protein quantification and CYP phenotyping will improve the prediction of drug metabolism and decrease the risk of drug-drug interactions.
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